Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals

SIMPLE SUMMARY: Owing to pegylated interferon (PegIFN)-free direct-acting antivirals (DAAs) against chronic hepatitis C virus infection, a sustained virological response (SVR) rate >95% can be attained with a satisfactory tolerability and shorter treatment duration. However, it still remains cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye Won, Han, Dai Hoon, Shin, Hye Jung, Lee, Jae Seung, Kim, Seung Up, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Kim, Beom Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698608/
https://www.ncbi.nlm.nih.gov/pubmed/33217965
http://dx.doi.org/10.3390/cancers12113414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698608/
https://www.ncbi.nlm.nih.gov/pubmed/33217965
http://dx.doi.org/10.3390/cancers12113414

Ejemplares similares